diuretics
These data may explain why, in the CAPP       trial, captopril which has prevented more effectively diabetes occurrence could       not be proved superior to diuretics and/or betablocker in the prevention of       myocardial infarction and specially of strokes for which exist on the contrary a        suspicion of a lower protection.
These data may explain why, in the CAPP       trial, captopril which has prevented more effectively diabetes occurrence could       not be proved superior to  @SUBJECT$  and/or betablocker in the  @PREDICAT$  of        @OBJECT$  and specially of strokes for which exist on the contrary a        suspicion of a lower protection.